This site is intended for healthcare professionals only
LoginRegister
USFDA concludes inspection with no 483 observations at Divis Labs Telangana facilityDivi's Labs elevates Nimmagadda Venkata Anirudh as President (Nutraceuticals)
Granules Pharma earns USFDA tentative nod for Attention Deficit Hyperactivity Disorder drugAlembic Pharma bags USFDA nod for blood cancer drug Dasatinib
Alembic Pharma secures USFDA approval for Travoprost Ophthalmic SolutionAlembic Pharma converts UAE branch office into wholly owned subsidiary
NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, DetailsNPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin,...
Big investment push: Sun Pharma Labs to set up Rs 3000 crore facility in MPSun Pharma open to enhance manufacturing footprint in US
Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosisDr. Reddy's Gets CDSCO Panel Nod for BE Study on Resmetirom Tablets for NASH Treatment
Aurobindo Pharma arm Eugia Pharma B.V incorporates new wholly owned subsidiary in ChileQ2 results: Aurobindo Pharma net profit rises 4 percent to Rs 848 crore
Solara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on DeleveragingSolara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on...
Strides Pharma Science arm New York facility gets 4 USFDA observationsSenores Pharma arm facility gets USFDA EIR
Sun Pharma Asked to Resubmit Revised Phase III Protocol for Delafloxacin CABP TrialSun Pharma net profit up 3 percent at Rs 3118 crore in Q2
Zydus-owned Sentynls Menkes disease drug NDA resubmission accepted by USFDAZydus gets USFDA Orphan Drug Designation for Desidustat for beta-thalassemia
Lupin gets USFDA EIR for Pithampur Unit 3 facilityLupin gets USFDA EIR for Pithampur Unit 3 facility
X